Logo image of HLI

HOULIHAN LOKEY INC (HLI) Stock Fundamental Analysis

USA - NYSE:HLI - US4415931009 - Common Stock

180.33 USD
+0.57 (+0.32%)
Last: 11/7/2025, 8:04:00 PM
180.33 USD
0 (0%)
After Hours: 11/7/2025, 8:04:00 PM
Fundamental Rating

6

Taking everything into account, HLI scores 6 out of 10 in our fundamental rating. HLI was compared to 237 industry peers in the Capital Markets industry. HLI has an excellent profitability rating, but there are some minor concerns on its financial health. HLI is growing strongly while it is still valued neutral. This is a good combination! This makes HLI very considerable for growth investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year HLI was profitable.
In the past year HLI had a positive cash flow from operations.
Each year in the past 5 years HLI has been profitable.
HLI had a positive operating cash flow in each of the past 5 years.
HLI Yearly Net Income VS EBIT VS OCF VS FCFHLI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of 11.61%, HLI belongs to the top of the industry, outperforming 91.98% of the companies in the same industry.
The Return On Equity of HLI (18.75%) is better than 85.65% of its industry peers.
The Return On Invested Capital of HLI (18.53%) is better than 94.51% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HLI is significantly above the industry average of 7.63%.
The 3 year average ROIC (15.77%) for HLI is below the current ROIC(18.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.61%
ROE 18.75%
ROIC 18.53%
ROA(3y)9.29%
ROA(5y)11.19%
ROE(3y)16.47%
ROE(5y)20.47%
ROIC(3y)15.77%
ROIC(5y)19.56%
HLI Yearly ROA, ROE, ROICHLI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

HLI has a Profit Margin (16.46%) which is in line with its industry peers.
HLI's Profit Margin has been stable in the last couple of years.
HLI has a Operating Margin (23.16%) which is in line with its industry peers.
In the last couple of years the Operating Margin of HLI has grown nicely.
Industry RankSector Rank
OM 23.16%
PM (TTM) 16.46%
GM N/A
OM growth 3Y-4.82%
OM growth 5Y3.29%
PM growth 3Y-4.63%
PM growth 5Y1.08%
GM growth 3YN/A
GM growth 5YN/A
HLI Yearly Profit, Operating, Gross MarginsHLI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

5

2. Health

2.1 Basic Checks

The number of shares outstanding for HLI has been increased compared to 1 year ago.
HLI has more shares outstanding than it did 5 years ago.
HLI has a better debt/assets ratio than last year.
HLI Yearly Shares OutstandingHLI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
HLI Yearly Total Debt VS Total AssetsHLI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

HLI has an Altman-Z score of 7.48. This indicates that HLI is financially healthy and has little risk of bankruptcy at the moment.
HLI has a better Altman-Z score (7.48) than 91.56% of its industry peers.
The Debt to FCF ratio of HLI is 0.02, which is an excellent value as it means it would take HLI, only 0.02 years of fcf income to pay off all of its debts.
HLI has a better Debt to FCF ratio (0.02) than 93.67% of its industry peers.
HLI has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
HLI has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. HLI outperforms 85.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.02
Altman-Z 7.48
ROIC/WACCN/A
WACCN/A
HLI Yearly LT Debt VS Equity VS FCFHLI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

HLI has a Current Ratio of 0.97. This is a bad value and indicates that HLI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.97, HLI is doing worse than 61.18% of the companies in the same industry.
A Quick Ratio of 0.97 indicates that HLI may have some problems paying its short term obligations.
HLI's Quick ratio of 0.97 is on the low side compared to the rest of the industry. HLI is outperformed by 60.76% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
HLI Yearly Current Assets VS Current LiabilitesHLI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 46.62% over the past year.
HLI shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.36% yearly.
HLI shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.01%.
Measured over the past years, HLI shows a quite strong growth in Revenue. The Revenue has been growing by 15.56% on average per year.
EPS 1Y (TTM)46.62%
EPS 3Y-4.01%
EPS 5Y14.36%
EPS Q2Q%26.03%
Revenue 1Y (TTM)21.01%
Revenue growth 3Y1.72%
Revenue growth 5Y15.56%
Sales Q2Q%14.7%

3.2 Future

The Earnings Per Share is expected to grow by 16.38% on average over the next years. This is quite good.
Based on estimates for the next years, HLI will show a quite strong growth in Revenue. The Revenue will grow by 13.08% on average per year.
EPS Next Y26.8%
EPS Next 2Y19.49%
EPS Next 3Y16.38%
EPS Next 5YN/A
Revenue Next Year15.49%
Revenue Next 2Y14.57%
Revenue Next 3Y13.08%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
HLI Yearly Revenue VS EstimatesHLI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
HLI Yearly EPS VS EstimatesHLI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

HLI is valuated rather expensively with a Price/Earnings ratio of 23.79.
Based on the Price/Earnings ratio, HLI is valued a bit more expensive than 64.13% of the companies in the same industry.
When comparing the Price/Earnings ratio of HLI to the average of the S&P500 Index (26.06), we can say HLI is valued inline with the index average.
The Price/Forward Earnings ratio is 20.11, which indicates a rather expensive current valuation of HLI.
The rest of the industry has a similar Price/Forward Earnings ratio as HLI.
HLI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 32.73.
Industry RankSector Rank
PE 23.79
Fwd PE 20.11
HLI Price Earnings VS Forward Price EarningsHLI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

73.84% of the companies in the same industry are more expensive than HLI, based on the Enterprise Value to EBITDA ratio.
HLI's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 17.15
EV/EBITDA 19.1
HLI Per share dataHLI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HLI has a very decent profitability rating, which may justify a higher PE ratio.
HLI's earnings are expected to grow with 16.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.89
PEG (5Y)1.66
EPS Next 2Y19.49%
EPS Next 3Y16.38%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.34%, HLI has a reasonable but not impressive dividend return.
HLI's Dividend Yield is slightly below the industry average, which is at 8.49.
Compared to an average S&P500 Dividend Yield of 2.37, HLI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.34%

5.2 History

The dividend of HLI is nicely growing with an annual growth rate of 14.04%!
HLI has been paying a dividend for at least 10 years, so it has a reliable track record.
HLI has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)14.04%
Div Incr Years9
Div Non Decr Years9
HLI Yearly Dividends per shareHLI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

HLI pays out 40.76% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of HLI is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP40.76%
EPS Next 2Y19.49%
EPS Next 3Y16.38%
HLI Yearly Income VS Free CF VS DividendHLI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
HLI Dividend Payout.HLI Dividend Payout, showing the Payout Ratio.HLI Dividend Payout.PayoutRetained Earnings

HOULIHAN LOKEY INC

NYSE:HLI (11/7/2025, 8:04:00 PM)

After market: 180.33 0 (0%)

180.33

+0.57 (+0.32%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)01-26 2026-01-26/amc
Inst Owners103.13%
Inst Owner Change1.49%
Ins Owners0.13%
Ins Owner Change2.97%
Market Cap12.68B
Revenue(TTM)2.57B
Net Income(TTM)408.30M
Analysts70
Price Target218.86 (21.37%)
Short Float %2.1%
Short Ratio2.87
Dividend
Industry RankSector Rank
Dividend Yield 1.34%
Yearly Dividend2.38
Dividend Growth(5Y)14.04%
DP40.76%
Div Incr Years9
Div Non Decr Years9
Ex-Date12-01 2025-12-01 (0.6)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.99%
Min EPS beat(2)19.63%
Max EPS beat(2)26.35%
EPS beat(4)4
Avg EPS beat(4)15.86%
Min EPS beat(4)7.29%
Max EPS beat(4)26.35%
EPS beat(8)8
Avg EPS beat(8)9.85%
EPS beat(12)10
Avg EPS beat(12)8%
EPS beat(16)14
Avg EPS beat(16)12.2%
Revenue beat(2)2
Avg Revenue beat(2)5.22%
Min Revenue beat(2)4.85%
Max Revenue beat(2)5.6%
Revenue beat(4)4
Avg Revenue beat(4)5.15%
Min Revenue beat(4)4.31%
Max Revenue beat(4)5.83%
Revenue beat(8)7
Avg Revenue beat(8)3.41%
Revenue beat(12)9
Avg Revenue beat(12)2.62%
Revenue beat(16)13
Avg Revenue beat(16)6.94%
PT rev (1m)3.46%
PT rev (3m)6.01%
EPS NQ rev (1m)3.47%
EPS NQ rev (3m)2.94%
EPS NY rev (1m)2.89%
EPS NY rev (3m)11.47%
Revenue NQ rev (1m)1.42%
Revenue NQ rev (3m)1.54%
Revenue NY rev (1m)0.73%
Revenue NY rev (3m)3.2%
Valuation
Industry RankSector Rank
PE 23.79
Fwd PE 20.11
P/S 5.11
P/FCF 17.15
P/OCF 16.22
P/B 5.82
P/tB 18.67
EV/EBITDA 19.1
EPS(TTM)7.58
EY4.2%
EPS(NY)8.97
Fwd EY4.97%
FCF(TTM)10.52
FCFY5.83%
OCF(TTM)11.11
OCFY6.16%
SpS35.29
BVpS30.97
TBVpS9.66
PEG (NY)0.89
PEG (5Y)1.66
Graham Number72.68
Profitability
Industry RankSector Rank
ROA 11.61%
ROE 18.75%
ROCE 25.21%
ROIC 18.53%
ROICexc 28.43%
ROICexgc N/A
OM 23.16%
PM (TTM) 16.46%
GM N/A
FCFM 29.8%
ROA(3y)9.29%
ROA(5y)11.19%
ROE(3y)16.47%
ROE(5y)20.47%
ROIC(3y)15.77%
ROIC(5y)19.56%
ROICexc(3y)27.01%
ROICexc(5y)39.46%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.46%
ROCE(5y)26.61%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-21.39%
ROICexc growth 5Y3.92%
OM growth 3Y-4.82%
OM growth 5Y3.29%
PM growth 3Y-4.63%
PM growth 5Y1.08%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.02
Debt/EBITDA 0.02
Cap/Depr 86.79%
Cap/Sales 1.69%
Interest Coverage 444.85
Cash Conversion 125.41%
Profit Quality 181.11%
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 7.48
F-Score9
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)139.05%
Cap/Depr(5y)105.57%
Cap/Sales(3y)2.65%
Cap/Sales(5y)1.85%
Profit Quality(3y)109.81%
Profit Quality(5y)135.31%
High Growth Momentum
Growth
EPS 1Y (TTM)46.62%
EPS 3Y-4.01%
EPS 5Y14.36%
EPS Q2Q%26.03%
EPS Next Y26.8%
EPS Next 2Y19.49%
EPS Next 3Y16.38%
EPS Next 5YN/A
Revenue 1Y (TTM)21.01%
Revenue growth 3Y1.72%
Revenue growth 5Y15.56%
Sales Q2Q%14.7%
Revenue Next Year15.49%
Revenue Next 2Y14.57%
Revenue Next 3Y13.08%
Revenue Next 5YN/A
EBIT growth 1Y49.24%
EBIT growth 3Y-3.18%
EBIT growth 5Y19.36%
EBIT Next Year40.71%
EBIT Next 3Y23.15%
EBIT Next 5YN/A
FCF growth 1Y237.97%
FCF growth 3Y3.58%
FCF growth 5Y24.82%
OCF growth 1Y178.41%
OCF growth 3Y4.83%
OCF growth 5Y24.15%

HOULIHAN LOKEY INC / HLI FAQ

What is the ChartMill fundamental rating of HOULIHAN LOKEY INC (HLI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to HLI.


Can you provide the valuation status for HOULIHAN LOKEY INC?

ChartMill assigns a valuation rating of 4 / 10 to HOULIHAN LOKEY INC (HLI). This can be considered as Fairly Valued.


How profitable is HOULIHAN LOKEY INC (HLI) stock?

HOULIHAN LOKEY INC (HLI) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for HLI stock?

The Price/Earnings (PE) ratio for HOULIHAN LOKEY INC (HLI) is 23.79 and the Price/Book (PB) ratio is 5.82.


Can you provide the financial health for HLI stock?

The financial health rating of HOULIHAN LOKEY INC (HLI) is 5 / 10.